|
|
Volumn 128, Issue 11, 2015, Pages 1253-1256
|
|
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria
a,b,c
|
|
Author keywords
Ezetimibe; IMPROVE IT; Moderate to high intensity statin therapy; Treatment practice
|
|
Indexed keywords
EZETIMIBE;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
ACUTE CORONARY SYNDROME;
AGED;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL (TOPIC);
DRUG USE;
FEMALE;
HEALTH CARE SYSTEM;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRESCRIPTION;
PRIORITY JOURNAL;
ADULT;
DRUG COMBINATION;
EVALUATION STUDY;
GOVERNMENT;
MIDDLE AGED;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
UNITED STATES;
ACUTE CORONARY SYNDROME;
ADULT;
AGED;
ANTICHOLESTEREMIC AGENTS;
DRUG THERAPY, COMBINATION;
EZETIMIBE;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SIMVASTATIN;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;
|
|
EID: 84946491890
PISSN: 00029343
EISSN: 15557162
Source Type: Journal
DOI: 10.1016/j.amjmed.2015.05.027 Document Type: Article |
|
Times cited : (9)
|
|
References (2)
|
